London Calling: Flagship Expands in U.K. to Build AI-Native Platform Companies

Flagship Pioneering, which for more than 25 years has created and nurtured startups—most notably mRNA vaccine giant Moderna—from Cambridge, MA, has launched its first dedicated company creation unit outside of the U.S. with an initial commitment of Ā£100 million ($131.66 million) that the venture capital giant expects to quintuple in coming years.

The new London-based Flagship Origination Lab U.K. has been established to conceive, test, fund, and build artificial intelligence (AI)-native platform companies that advance human and planetary health and other frontiers of science and technology.

Flagship said the U.K. Lab will operate as part of Flagship Labs, the company’s innovation foundry, with the goal of creating a locally rooted company-creation ecosystem in the United Kingdom that connects to Flagship’s broader global ecosystem, including business units and: